Jonathan Stuart Kaplan
Examiner (ID: 15168)
Most Active Art Unit | 2836 |
Art Unit(s) | 2107, 2104, 2836 |
Total Applications | 226 |
Issued Applications | 203 |
Pending Applications | 10 |
Abandoned Applications | 13 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5710397
[patent_doc_number] => 20060051742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Novel assay for the separation and quantification of hemagglutinin antigens'
[patent_app_type] => utility
[patent_app_number] => 11/119631
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 12661
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051742.pdf
[firstpage_image] =>[orig_patent_app_number] => 11119631
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/119631 | Assay for the separation and quantification of hemagglutinin antigens | May 1, 2005 | Issued |
Array
(
[id] => 5799338
[patent_doc_number] => 20060034859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Naturally processed measles virus peptides eluted from class II HLA molecules'
[patent_app_type] => utility
[patent_app_number] => 11/116682
[patent_app_country] => US
[patent_app_date] => 2005-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 27247
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034859.pdf
[firstpage_image] =>[orig_patent_app_number] => 11116682
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/116682 | Naturally processed measles virus peptides eluted from class II HLA molecules | Apr 27, 2005 | Abandoned |
Array
(
[id] => 232653
[patent_doc_number] => 07598078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-06
[patent_title] => 'Settings for recombinant adenoviral-based vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/105725
[patent_app_country] => US
[patent_app_date] => 2005-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 38
[patent_no_of_words] => 18905
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/598/07598078.pdf
[firstpage_image] =>[orig_patent_app_number] => 11105725
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/105725 | Settings for recombinant adenoviral-based vaccines | Apr 13, 2005 | Issued |
Array
(
[id] => 4977221
[patent_doc_number] => 20070218453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Sensing Tool'
[patent_app_type] => utility
[patent_app_number] => 10/594612
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12961
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218453.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594612
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594612 | Sensing Tool | Mar 28, 2005 | Abandoned |
Array
(
[id] => 5601806
[patent_doc_number] => 20060292151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'L-SIGN polymorphisms and methods involving use of same'
[patent_app_type] => utility
[patent_app_number] => 11/093117
[patent_app_country] => US
[patent_app_date] => 2005-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 33339
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292151.pdf
[firstpage_image] =>[orig_patent_app_number] => 11093117
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/093117 | L-SIGN polymorphisms and methods involving use of same | Mar 27, 2005 | Abandoned |
Array
(
[id] => 4574157
[patent_doc_number] => 07829667
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-09
[patent_title] => 'Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same'
[patent_app_type] => utility
[patent_app_number] => 10/593413
[patent_app_country] => US
[patent_app_date] => 2005-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 11481
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/829/07829667.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593413
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593413 | Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same | Mar 17, 2005 | Issued |
Array
(
[id] => 5769522
[patent_doc_number] => 20050266015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide'
[patent_app_type] => utility
[patent_app_number] => 11/078654
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 4745
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20050266015.pdf
[firstpage_image] =>[orig_patent_app_number] => 11078654
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/078654 | Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide | Mar 10, 2005 | Abandoned |
Array
(
[id] => 5705169
[patent_doc_number] => 20060194217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Method of genotyping and phenotyping hepatitis B viruses resistant to antiviral molecules'
[patent_app_type] => utility
[patent_app_number] => 11/077359
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14719
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194217.pdf
[firstpage_image] =>[orig_patent_app_number] => 11077359
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/077359 | Method of genotyping and phenotyping hepatitis B viruses resistant to antiviral molecules | Mar 10, 2005 | Abandoned |
Array
(
[id] => 606147
[patent_doc_number] => 07153512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-26
[patent_title] => 'Bovine immunodeficiency virus (BIV) based vectors'
[patent_app_type] => utility
[patent_app_number] => 11/076353
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17444
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/153/07153512.pdf
[firstpage_image] =>[orig_patent_app_number] => 11076353
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/076353 | Bovine immunodeficiency virus (BIV) based vectors | Mar 7, 2005 | Issued |
Array
(
[id] => 7111205
[patent_doc_number] => 20050208660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Bovine immunodeficiency virus (BIV) based vectors'
[patent_app_type] => utility
[patent_app_number] => 11/076190
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17446
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208660.pdf
[firstpage_image] =>[orig_patent_app_number] => 11076190
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/076190 | Bovine immunodeficiency virus (BIV) based vectors | Mar 7, 2005 | Issued |
Array
(
[id] => 33054
[patent_doc_number] => 07785877
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Bovine immunodeficiency virus (BIV) based vectors'
[patent_app_type] => utility
[patent_app_number] => 11/076399
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17415
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/785/07785877.pdf
[firstpage_image] =>[orig_patent_app_number] => 11076399
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/076399 | Bovine immunodeficiency virus (BIV) based vectors | Mar 7, 2005 | Issued |
Array
(
[id] => 5069054
[patent_doc_number] => 20070190155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Molecular programming of nanoparticle systems for an ordered and controlled sequence of events for gene-drug delivery'
[patent_app_type] => utility
[patent_app_number] => 10/591213
[patent_app_country] => US
[patent_app_date] => 2005-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15395
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20070190155.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591213
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591213 | Molecular programming of nanoparticle systems for an ordered and controlled sequence of events for gene-drug delivery | Mar 3, 2005 | Abandoned |
Array
(
[id] => 863904
[patent_doc_number] => 07368118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-06
[patent_title] => 'Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus'
[patent_app_type] => utility
[patent_app_number] => 11/068710
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 13842
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/368/07368118.pdf
[firstpage_image] =>[orig_patent_app_number] => 11068710
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/068710 | Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus | Feb 27, 2005 | Issued |
Array
(
[id] => 6958380
[patent_doc_number] => 20050214750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Compositions and methods for determining the replication capacity of a pathogenic virus'
[patent_app_type] => utility
[patent_app_number] => 11/052741
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 19751
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214750.pdf
[firstpage_image] =>[orig_patent_app_number] => 11052741
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/052741 | Compositions and methods for determining the replication capacity of a pathogenic virus | Feb 3, 2005 | Abandoned |
Array
(
[id] => 7097676
[patent_doc_number] => 20050130135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/051613
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 28241
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130135.pdf
[firstpage_image] =>[orig_patent_app_number] => 11051613
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/051613 | Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof | Feb 3, 2005 | Abandoned |
Array
(
[id] => 588227
[patent_doc_number] => 07435539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-14
[patent_title] => 'Typing of human enteroviruses'
[patent_app_type] => utility
[patent_app_number] => 11/042898
[patent_app_country] => US
[patent_app_date] => 2005-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15446
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 444
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/435/07435539.pdf
[firstpage_image] =>[orig_patent_app_number] => 11042898
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/042898 | Typing of human enteroviruses | Jan 24, 2005 | Issued |
Array
(
[id] => 5894804
[patent_doc_number] => 20060003343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Primer and probe design for efficient amplification and detection of HCV 3\' non-translating region'
[patent_app_type] => utility
[patent_app_number] => 11/040417
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6781
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003343.pdf
[firstpage_image] =>[orig_patent_app_number] => 11040417
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/040417 | Primer and probe design for efficient amplification and detection of HCV 3' non-translating region | Jan 20, 2005 | Abandoned |
Array
(
[id] => 6088007
[patent_doc_number] => 20110217332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'Chimpanzee Adenovirus Vaccine Carriers'
[patent_app_type] => utility
[patent_app_number] => 10/587389
[patent_app_country] => US
[patent_app_date] => 2005-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 101
[patent_figures_cnt] => 101
[patent_no_of_words] => 26015
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10587389
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587389 | Chimpanzee adenovirus vaccine carriers | Jan 17, 2005 | Issued |
Array
(
[id] => 7172009
[patent_doc_number] => 20050203015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Angiogenesis regulation system'
[patent_app_type] => utility
[patent_app_number] => 11/022582
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6434
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203015.pdf
[firstpage_image] =>[orig_patent_app_number] => 11022582
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/022582 | Angiogenesis regulation system | Dec 22, 2004 | Issued |
Array
(
[id] => 7038909
[patent_doc_number] => 20050158343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus'
[patent_app_type] => utility
[patent_app_number] => 11/018177
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 22605
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158343.pdf
[firstpage_image] =>[orig_patent_app_number] => 11018177
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/018177 | Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus | Dec 20, 2004 | Abandoned |